comparemela.com

Latest Breaking News On - Superficial femoral - Page 1 : comparemela.com

Concept Medical s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA) – Padovanews

padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.

United statesManish doshiConcept medical incCompany sirolimusConcept medical groupConcept medical inc sirolimus coated balloonInvestigational device exemptionSirolimus coated balloonSuperficial femoral arteriesIn stent restenosisCoronary small vesselPeripheral arterial diseaseNorth americaConcept medicalSirolimus drug coated balloonSuperficial femoral

Concept Medical s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

/PRNewswire/ The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc s Sirolimus Coated.

United statesManish doshiCompany sirolimusConcept medical incConcept medical inc sirolimus coated balloonConcept medical groupInvestigational device exemptionSirolimus coated balloonSuperficial femoral arteriesIn stent restenosisCoronary small vesselPeripheral arterial diseaseNorth americaConcept medicalSirolimus drug coated balloonSuperficial femoral

Concept Medical s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease SFA

(This story has not been edited by THE WEEK and is auto-generated from a PTI

United statesManish doshiConcept medical incCompany sirolimusConcept medical groupConcept medical inc sirolimus coated balloonInvestigational device exemptionSirolimus coated balloonSuperficial femoral arteriesIn stent restenosisCoronary small vesselPeripheral arterial diseaseNorth americaConcept medicalSirolimus drug coated balloonSuperficial femoral

Concept Medical s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval forThe Company has already received three other pivotal IDE appr

United statesManish doshiConcept medical groupNanolute technologyInvestigational device exemptionIn stent restenosisCoronary small vesselPeripheral arterial diseaseNorth americaConcept medicalSuperficial femoralBelow the knee

Paclitaxel-Eluting Stent for Treating Symptomatic Femoropopliteal PAD

In patients with symptomatic femoropopliteal PAD, use of polymer-coated, paclitaxel-eluting stents show superior 1-year primary patency.

United statesBoston scientificSuperficial femoralProximal popliteal artery

vimarsana © 2020. All Rights Reserved.